RISHP CE Event - Immunization and Patient Safety CE

  • Thursday, March 21, 2019
  • 5:00 PM - 8:30 PM
  • Wyndham Providence 1850 Post Road, Warwick, RI 02886
  • 48

Registration


Registration is closed

Rhode Island Society of Health System Pharmacists 

CE Event

Pharmacists and Pharmacy Technicians

2.0 Contact Hours (0.2 CEUs)

March 21, 2019

Wyndham Hotel

1850 Post Road, Warwick, RI 02886

(401) 738-4000

Topics:

Herpes Zoster: A Review of the Recombinant and Live Zoster Vaccines
Missy Riester, PharmD, PGY1 Pharmacy Practice Resident, Rhode Island Hospital

Overview of Checkpoint Inhibitors: Current Uses, Associated Risks, and Future Directions
Mark Sorial, PharmD, PGY1 Pharmacy Practice Resident, Rhode Island Hospital

Program Agenda:
5:00 PM Registration
5:45 PM Dinner Buffet Begins

6:00 PM Herpes Zoster: A Review of the Recombinant and Live Zoster Vaccines

7:00 PM Coffee Break
7:15 PM Overview of Checkpoint Inhibitors: Current Uses, Associated Risks, and Future Directions

Members $25.00
Non-Members:  $50.00
Please register on-line only. Please do not mail in registrations. Fees are payable at sign-in or online via Paypal Online:http://www.rishp.org. Refund requests must be made by written request and are at the discretion of the RISHP Board of Directors.

Learning Objectives

Upon completion of this learning activity, pharmacist participants will be able to:

Herpes Zoster: A Review of the Recombinant and Live Zoster Vaccines

  1. Evaluate current literature supporting the use of the recombinant zoster vaccine
  2. Identify patients who should receive a Herpes Zoster vaccine
  3. Compare and contrast the storage and handling requirements of the recombinant and live zoster vaccines 
  4. Outline the steps required to prepare and administer the recombinant and live zoster vaccines

Overview of Checkpoint Inhibitors: Current Uses, Associated Risks, and Future Directions

  1. Describe the different immunotherapy agents and their mechanisms of action.
  2. Evaluate the literature regarding the use of checkpoint inhibitors.
  3. Summarize the risks associated with checkpoint inhibitors.
  4. Identify future approaches to cancer treatment.

    Upon completion of this learning activity, technician participants will be able to:

    Herpes Zoster: A Review of the Recombinant and Live Zoster Vaccines

    1. Identify patients who should receive a Herpes Zoster vaccine
    2. Compare and contrast the storage and handling requirements of the recombinant and live zoster vaccines
    3. Outline the steps required to prepare and administer the recombinant and live zoster vaccines

    Overview of Checkpoint Inhibitors: Current Uses, Associated Risks, and Future Directions

    1. Describe the different immunotherapy agents and their mechanisms of action.
    2. List the risks associated with checkpoint inhibitors
    3. Identify future approaches to cancer treatment.

    The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based educational activity. Pharmacists and pharmacy technicians will receive 2.0 contact hours (0.20 ceus) for the educational activity.
    Rhode Island Society of Health System Pharmacists Residents Pearls 2.0 Contact Hours (0.2 CEUs)
    Pharmacists UAN: 0060‐9999‐19‐017‐L06‐P (Immunization CE), 0060‐9999‐19‐018‐L05‐P (Patient Safety CE)
    Technicians UAN: 0060‐9999‐19‐017‐L06‐T (Immunization CE), 0060‐9999‐19‐018‐L05‐T (Patient Safety CE)






      For website issues issues, please click here

      Powered by Wild Apricot Membership Software